Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2 | -8,216 | -5,883 | -4,061 | -2,351 |
| Depreciation Amortization | 280 | 990 | 744 | 543 | 274 |
| Accounts receivable | 53 | -1,932 | -1,421 | -1,166 | -909 |
| Accounts payable and accrued liabilities | -460 | 455 | 350 | 1,005 | -17 |
| Other Working Capital | -2,496 | -1,106 | -1,905 | 792 | -249 |
| Other Operating Activity | 337 | 2,078 | 944 | 69 | 1,026 |
| Operating Cash Flow | $-2,288 | $-7,730 | $-7,171 | $-2,817 | $-2,226 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174 | -269 | -173 | -59 | -12 |
| Investing Cash Flow | $-174 | $-269 | $-173 | $-59 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,159 | 8,046 | 1,955 | N/A | N/A |
| Debt Issued | 1,704 | 6,804 | 13,063 | 3,252 | -195 |
| Debt Repayment | 17,039 | -8,537 | -9,298 | -439 | -49 |
| Other Financing Activity | -6,114 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $2,471 | $6,313 | $5,719 | $2,813 | $-243 |
| Exchange Rate Effect | 5 | 8 | 7 | 49 | 17 |
| Beginning Cash Position | 2,330 | 4,008 | 4,008 | 4,008 | 4,008 |
| End Cash Position | 2,344 | 2,330 | 2,391 | 3,994 | 1,544 |
| Net Cash Flow | $14 | $-1,678 | $-1,617 | $-14 | $-2,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,288 | -7,730 | -7,171 | -2,817 | -2,226 |
| Capital Expenditure | -174 | -269 | -173 | -59 | -12 |
| Free Cash Flow | -2,461 | -7,999 | -7,344 | -2,876 | -2,238 |